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Abstract.  The  first  symptoms  of  malaria,  common  to  all  the  different  malaria  species,  are 
nonspecific and mimic a flu-like syndrome. Although fever represents the cardinal feature, clinical 
findings in malaria are extremely diverse and may range in severity from mil
complications  leading to death,  particularly in falciparum malaria. As the progression  to these 
complications can be rapid, any malaria patient must be assessed and treated rapidly, and frequent 
observations are needed to look for ear
In fact, severe malaria is a life threatening but treatable disease.  The protean and nonspecific 
clinical findings occurring in malaria (fever, malaise, headache, myalgias, jaundice and sometimes 
gastrointestinal symptoms of nausea, vomiting and diarrhoea) may lead physicians who see malaria 
infrequently to a wrong diagnosis, such as influenza (particularly during the seasonal epidemic flu), 
dengue, gastroenteritis, typhoid fever, viral hepatitis, encephalitis. Physicia
malaria is not a clinical diagnosis but must be diagnosed, or excluded, by performing microscopic 
examination  of  blood  films.  Prompt  diagnosis  and  appropriate  treatment  are  then  crucial  to 
prevent morbidity and fatal outcomes. Altho
of severe malaria and death, increasing evidence has recently emerged that 
Plasmodium knowlesi can also be severe and even fatal. 
Introduction. Malaria  is  usually  transmitted  by  the 
bite  of  an  infected  female  anopheline  mosquito, 
although  blood-borne  transmission  (blood  or  blood 
products  transfusion,  transplantation,  needle
among intravenous drug addicts, accidental nosocomial 
transmission) or congenital transmission may occur.
In  the  case  of  mosquito-borne  transmission, 
sporozoites,  the  infective  plasmodial  stage  injected 
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The  first  symptoms  of  malaria,  common  to  all  the  different  malaria  species,  are 
like syndrome. Although fever represents the cardinal feature, clinical 
findings in malaria are extremely diverse and may range in severity from mil
complications  leading to death,  particularly in falciparum malaria. As the progression  to these 
complications can be rapid, any malaria patient must be assessed and treated rapidly, and frequent 
observations are needed to look for early signs of systemic complications. 
In fact, severe malaria is a life threatening but treatable disease.  The protean and nonspecific 
clinical findings occurring in malaria (fever, malaise, headache, myalgias, jaundice and sometimes 
oms of nausea, vomiting and diarrhoea) may lead physicians who see malaria 
infrequently to a wrong diagnosis, such as influenza (particularly during the seasonal epidemic flu), 
dengue, gastroenteritis, typhoid fever, viral hepatitis, encephalitis. Physicians should be aware that 
malaria is not a clinical diagnosis but must be diagnosed, or excluded, by performing microscopic 
examination  of  blood  films.  Prompt  diagnosis  and  appropriate  treatment  are  then  crucial  to 
prevent morbidity and fatal outcomes. Although Plasmodium falciparum malaria is the major cause 
of severe malaria and death, increasing evidence has recently emerged that 
can also be severe and even fatal. 
Malaria  is  usually  transmitted  by  the 
bite  of  an  infected  female  anopheline  mosquito, 
borne  transmission  (blood  or  blood 
products  transfusion,  transplantation,  needle-sharing 
intravenous drug addicts, accidental nosocomial 
transmission) or congenital transmission may occur.
1
borne  transmission, 
sporozoites,  the  infective  plasmodial  stage  injected 
along  with  saliva  into  subcutaneous  capillaries, 
disappear  from  the  blood  within  approximately  45 
minutes of the bite and enter liver parenchimal cells 
(hepatocytes). Inside the hepatocytes, each sporozoite 
begins a phase of asexual reproduction resulting in the
formation of a schizont, which contains thousands of 
merozoites. The rupture of mature schizonts generates 
the liberation of merozoites into the bloodstream. The 
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The  first  symptoms  of  malaria,  common  to  all  the  different  malaria  species,  are 
like syndrome. Although fever represents the cardinal feature, clinical 
findings in malaria are extremely diverse and may range in severity from mild headache to serious 
complications  leading to death,  particularly in falciparum malaria. As the progression  to these 
complications can be rapid, any malaria patient must be assessed and treated rapidly, and frequent 
In fact, severe malaria is a life threatening but treatable disease.  The protean and nonspecific 
clinical findings occurring in malaria (fever, malaise, headache, myalgias, jaundice and sometimes 
oms of nausea, vomiting and diarrhoea) may lead physicians who see malaria 
infrequently to a wrong diagnosis, such as influenza (particularly during the seasonal epidemic flu), 
ns should be aware that 
malaria is not a clinical diagnosis but must be diagnosed, or excluded, by performing microscopic 
examination  of  blood  films.  Prompt  diagnosis  and  appropriate  treatment  are  then  crucial  to 
malaria is the major cause 
of severe malaria and death, increasing evidence has recently emerged that Plasmodium vivax and 
with  saliva  into  subcutaneous  capillaries, 
disappear  from  the  blood  within  approximately  45 
minutes of the bite and enter liver parenchimal cells 
(hepatocytes). Inside the hepatocytes, each sporozoite 
begins a phase of asexual reproduction resulting in the
formation of a schizont, which contains thousands of 
merozoites. The rupture of mature schizonts generates 
the liberation of merozoites into the bloodstream. The Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
hepatic  phase  of  parasite  development  (hepatic 
schizogony) lasts on average between 5.5 (Plasmodium 
falciparum)  and  15  days  (Plasmodium  malariae).  In 
case  of  Plasmodium  vivax and  Plasmodium  ovale
infections,  a  proportion  of  parasites  may  remain 
dormant  in  hepatocytes  as  hypnozoites  for  several 
months up to 5 years. From the clinical point of view,
the hepatic schizogony is asymptomatic, as only a few 
number of liver cells is infected.
2
Once  in  the  bloodstream,  merozoites  reach  and 
invade red cells rapidly to start a process of asexual 
multiplication  (erythrocytic  schizogony).  Within  the 
red blood cell, merozoites mature to trophozoites and 
schizonts,  which  then  rupture  liberating  the  new 
generation  of  merozoites  to  invade  other  red  blood 
cells and thus continue the erythrocytic cycle. 
At  the  time  of  schizont  rupture,  the  release  of 
malaria  parasites  and  erythrocytic  material  into  the 
circulation  induce  the  pathophysiology  process  of 
malaria and the onset of symptoms. 
The  activation  of  the  cytokine  cascade  is 
responsible  of  many  of  the  symptoms  and  signs  of 
malaria.
Uncomplicated Malaria. While the interval from time 
of  infection  until  parasites  become  detectable  in  the 
blood  is  termed  prepatent  period,  with  the  term  of 
incubation  period  is  defined  the  interval  between 
infection and the onset of symptoms. The duration of 
incubation period is influenced by several factors such 
as the species of infecting parasites, the way of parasite 
transmission, the degree of previous immune status of 
the  host,  the  chemoprophylactic  use  of  antimalarial 
drugs,  and  probably  the  density  of  parasite  inocula. 
Incubation  period ranges  from 9  to  30  days with  P. 
falciparum infections, tending to present the shortest, 
and P. malariae the more prolonged times. In most of 
P.  falciparum and  P.  vivax malaria,  the  incubation 
period is approximately two weeks. In blood-induced 
infections, the incubation period is usually shorter with 
symptoms developing within 10 days of transfusion for 
P. falciparum, 16 days for P. vivax, and 40 days or 
longer  for  P.  malariae.
1 As  far  as  the  degree  of 
previous protection possessed by the infected subject is 
concerned,  it  is  known  that  effective  immunity 
prolongs  incubation  period  and  reduces  level  of 
parasitemia  and  clinical  manifestations.  Low 
asymptomatic parasitemia may persist in migrants from 
endemic  areas  long  after  their  arrival  in  the  host 
country,
1 and  delayed  clinical  presentation  of  P. 




5 after subjects have left malaria-endemic 
areas. Pregnancy and co-infection with HIV have been 
associated with late presentation of malaria caused by 
P. falciparum in immigrants.
6
Prolonged incubation period may also be caused by 
the use of antimalarial drugs that, although ineffective, 
may impact on the parasite multiplication rate. 
The clinical manifestations of malaria are dependent 
on the previous immune status of the host.
7 In areas 
where endemicity of P. falciparum malaria is stable, 
severe malaria most commonly occurs in children up to 
5 years of age, while is less common in older children 
and  adults  because  of  the  acquisition  of  partial 
immunity.  In  areas  of  lower  endemicity,  the  age 
distribution of severe malaria is less well defined and 
may also occur in adult semi-immune persons. 
The first symptoms of malaria, common to all the 
different malaria species, are nonspecific and mimic a 
flu-like syndrome.  The  hallmark of  malaria is  fever.  
Up to two days before the onset of fever, prodromal 
symptoms,  such  as  malaise,  anorexia,  lassitude, 
dizziness,  with  a  desire  to  stretch  limbs  and  yawn, 
headache,  backache  in  the  lumbar  and  sacroiliac 
region,  myalgias,  nausea,  vomiting  and  a  sense  of 
chillness  may  be  experienced.
8 The  fever  is  usually 
irregular  at  first  and  the  temperature  rises  with 
shivering and mild chills. After some days fever tends 
to  become  periodic  depending  on  the  synchronized 
schizogony. In fact, for unknown reasons development 
of asexual blood stage parasites becomes synchronous 
after  some days with  a periodicity depending on the 
length of the asexual cycle. 
Plasmodium vivax and Plasmodium ovale. In P. vivax
and P. ovale infection, if left untreated, asexual cycles 
become synchronous after 5 to 7 days causing periodic 
febrile  paroxysms.  The  classical  malaria  paroxysm 
presents three stages: a cold stage, followed by a hot 
stage with a terminal sweating stage. The cold stage is 
typically characterized by a sudden onset with a feeling 
of extreme coldness. The subject may shiver and his or 
her teeth may chatter. In virtue of an intense peripheral 
vasoconstriction  phenomenon,  the  skin  is  cold,  dry, 
pale, cyanosed and sometimes goose-pimpled.
1,7,8 The 
subject  feels  the  need  to  cover  himself  with  all 
available blankets he can reach, but without obtaining 
comfort. During this initial stage, that usually lasts 10-
30 minutes and only occasionally up to 90 minutes, the 
temperature rises gradually to a peak (usually between 
39° and 41° C). Eventually, the shivering ceases and 
the second or hot stage starts. The skin is now hot and 
dry and the face flushed, with the subject that feels heat 
and discards blanket. The temperature may further rise 
and reach hyperpyrexial levels. Vomiting is common in 
this  phase  and  sometimes  diarrhoea,  severe  retro-
orbital  headache,  parched  throat,  extreme  thirst,  and 
altered  consciousness  are  also  present.  In  young 
children convulsion may occur. Within 2-6 hours, the 
subject  enters  the  third  stage  of  the  paroxysm,  the Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
sweating  stage,  with  sudden  profuse  sweating, 
appearing first  at  the  temples, and  rapidly becoming 
generalized and copious. The temperature falls rapidly 
and  the  subject  feels  well,  although  extremely  tired, 
and usually falls asleep. The sweating stage lasts 2 to 3 
hours,  with  the  entire  paroxysm,  which  more 
frequently begins in late afternoon or evening, lasting 
6-10 hours.
At the physical examination, splenomegaly may be 
present during the acute attack but is more commonly 
observed after the second week of the attack. Rupture 
of  an  enlarged  spleen  is  a  possible,  although  rare, 
complication.  The  liver  may  also  be  enlarged  and 
palpable.
As far as laboratory findings are concerned, some 
degree of anaemia and reticulocytosis may be present 
due to lisys of parasitized and unparasitized red blood 
cells.  Thrombocytopenia  is  common  and  sometimes 
mild leucopenia is present. By examining blood films, 
representatives  of  all  developmental  forms  of  the 
asexual parasite, from the early ring to mature schizont, 
may  be  observed,  while  gametocytes  are  usually 
present after a period of about a week. The density of 
parasitemia seldom exceeds 2% of the erythrocytes.
In  P.  vivax and  P.  ovale infection,  schizogony 
occurs  every  48  hours  so  that  the  febrile  paroxysm 
occurs  every  third  day  (tertian  fever).  During  the 
intervals  between  febrile  paroxysm,  the  subject  is 
usually afebrile and feels well.  If left untreated, the 
attacks may last from a few weeks to some months and 
then spontaneously and gradually resolve. In P. vivax
and  P.  ovale infection,  after  a  quiescent  or  latent 
period,  relapse  may  occur  with  renewal  of  clinical 
symptoms and asexual parasitemia. This phenomenon 
is  due  to  reinvasion  of  the  blood  by  merozoites 
produced when hypnozoites awake from dormancy and 
develop into hepatic schizont. Relapses occur weeks, 
months, or even years after the primary infection with 
different  timing  related  to  the  P.  vivax    strain,  
geographical origin of the infection and the previous 
use  of  inadequate  antimalarial  treatment.  From  the 
clinical  point  of  view,  relapse  is  similar  to  the  first 
attack, except for a more abrupt onset and the absence 
of the initial period of irregular fever, as the infection
is more synchronous. The relapse is usually less severe 
and of shorter duration than the first attack.
Infections  with  P.  vivax and  P.  ovale are  rarely 
complicated. However, there is increasing evidence of 
serious  and  fatal  complications  due  to  P.  vivax
infection.
9-12
Plasmodium falciparum. In P. falciparum malaria, the 
onset  of  fever  occurs  after  few  days  of  prodromal 
symptoms started during the last days of the incubation 
period  (normal  range  9-14  days).  At  first,  fever  is 
irregular,  but  usually  occurs  daily.  It  may  be 
intermittent  or  continuous,  and  shows  no  sign  of 
periodicity until the illness has continued for a week or 
more. The symptoms present in the prodromal phase 
continue  and  increase,  so  configuring  a  flu-like 
syndrome. Anorexia, dispepsia, epigastric discomfort, 
nausea, vomiting and watery diarrhoea are frequent and 
may  be  misdiagnosed  as  a  gastrointestinal  infection. 
Herpes labialis may be present. A dry cough and an 
increase  in  the  respiration  rate  may  be  observed, 
arising  the  suspect  of  an  acute  respiratory  infection. 
Other  non-specific  physical  findings  are  tender 
hepatosplenomegaly,    orthostatic  hypotension,    and 
some degree of jaundice. The pulse may be rapid (100 
to 120 beats/min) and the blood pressure may be low 
(90-100  mmHg,  systolic).
13 When  periodic  febrile 
paroxysms occur, they may be daily (quotidian), every 
third  day  (tertian)  or  at  about  36-hour  intervals 
(subtertian). 
Routine  laboratory  exams  may  show  little  or  no 
anaemia in  mild  cases  and  in  otherwise  healthy 
individuals. When present, it is usually normochromic 
and  normocytic.  The  reticulocyte count is  normal  or 
depressed despite haemolysis, and increases only after 
the parasitemia is cleared. Serum haptoglobin may be 
undetectable  indicating  haemolysis.  However,  the 
degree of anaemia may greatly vary and is not always 
an indication of the severity of the attack. 
The  white  cell  count  is  usually  normal,  but 
leucopenia with a count of 3,000-6000 cells/μl may be 
observed.  Thrombocytopenia  is  common  (usually 
around  100,000/μl)  and  does  not  correlate  with 
severity.  Serum  transaminases  and  lactic 
dehydrogenase usually are moderately elevated as well 
as  bilirubin  concentrations,  both  conjugated 
(hepatocyte  disfunction  and/or  cholestasis)  and 
unconjugated  (haemolysis).  Prothrombin  and  partial 
tromboplastin time may be prolonged while fibrinogen 
levels  are  usually  elevated.  C-reactive  protein  and 
procalcitonin  value  are  usually  increased  in  both
uncomplicated  and  severe  malaria  with  levels 
correlated  with  parasitemia  and  prognosis  according 
with some studies.
14-16 Hyponatremia is not uncommon 
and,  in  some  cases,  a  transient  increase  in  serum 
creatinine and blood urea nitrogen may be observed. 
Urine analysis reveals albuminuria and urobilinogen. 
Examination of peripheral blood film mostly reveals 
the presence of early trophozoites (typical small ring 
forms),  often  numerous,  with  multiple  infected  red 
blood cells.  Late trophozoites, as well as schizonts, are 
seldom observed, being their presence an indicator of  
very  heavy  infections  and  poor  prognosis. 
Gametocytaemia  usually  occurs  in  the  second  week 
after the onset of parasitemia and may persist for some 
weeks after cure.
1Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Although  the  subject  may  not  appear  very  ill, 
serious  complications  may  develop  at  any  stage.  In 
non-immune  people  P.  falciparum malaria  may 
progress  very  rapidly  to  severe  malaria  unless 
appropriate treatment is started. If the acute attack is 
rapidly diagnosed and adequately treated, the prognosis 
of falciparum malaria is good, even if complications 
may still occur. The response to treatment is usually 
rapid  with  resolution  of  fever  and  most  symptoms 
within 3 days.
7 Recrudescence with renewal of clinical 
manifestation  and/or  parasitemia,  due  to  persistent 
erythrocytic forms, may occur.
Plasmodium malariae. P. malariae causes the mildest 
and most persistent form of malaria infection.
1 After an 
incubation period that is never less than 18 days, but 
that  may  be  up  to  30-40 days, prodromal symptoms 
resembling  those of vivax malaria proceeds  the onset 
of fever. The clinical picture of the primary attack is 
similar  to  that  of  vivax  malaria.  The  onset  is  often 
insidious, but febrile paroxysms, often occurring in the 
late  afternoon,  show  well  synchronized  schizogony 
from  an  early  stage  and  are  typically  separated  by 
intervals of 72 hours (quartan malaria). 
As  far  as  laboratory  findings  are  concerned, 
anaemia is  less  pronounced  and  leucopenia  may  be 
observed.  Parasitemia  rarely  exceeds  1%  of 
erythrocytes.  Representatives  of  all  developmental 
forms of the asexual parasite are usually present. Left 
untreated, the acute attack is self limiting but may last 
for  several  months  before  spontaneous  remission 
occurs.
1 Severe complications of P. malariae infection 
are  rarely  observed.  However,  recrudescences  may 
occur, more frequently during the first year and then at 
longer intervals, even after 30-50 years.  P. malariae
has no hypnozoite form, so recrudescences arise from 
persisting  blood  stage.  Asymptomatic  P.  malariae 
parasitemia  in  blood  donors  may  cause  transfusion 
malaria.
P. malariae infection is associated with development 
of  a  nephrotic  syndrome.  First  clinical  manifestation 
often onsets before 15 years of age. Classically, edema 
and ascites are present and accompanied by laboratory 
evidence of heavy proteinuria, hypoalbuminemia and 
hyperlipidemia. P. malariae parasitemia is common in 
children, but not in adults. Transient clinical remissions 
with period of asymptomatic proteinuria are frequent 
but progressive deterioration and development of renal 
failure often occur within 3 to 5 years.
13
Plasmodium  knowlesi.  P.  knowlesi is  the  species  of 
plasmodium most recently identified as agent of human 
malaria.
17 Until few years ago, it was known as agent 
of  chronic  infection  of  the  long-tailed  (Macaca 
fascicularis)  and  pig-tailed  (Macaca  nemestrina) 
macaques.
18 P. knowlesi malaria is the most common 
locally acquired human malaria in Malaysian Borneo 
(~70%  of  malaria  cases),
19 with  the  disease  also 
reported from other countries of southern and eastern 
Asia.
20 On  the  basis  of  clinical  features,  it  is  not 
possible to distinguish knowlesi malaria from vivax or 
falciparum  malaria.
19 The  development  of 
hyperparasitemia  and  other  complications    are  fairly 
common.
19 Concerning diagnosis, the identification of 
P.  knowlesi  infection  by  using  microscopy  only  is 
difficult  because  it  is  very  similar  to  P.  malariae.
21  
Polymerase  Chain  Reaction  (PCR)  is  currently  the 
method of choice to obtain a certain diagnosis.
17
Severe  Malaria.  Most  of  the  severe  malaria 
complications  occur  in  non  immune  subjects  with 
falciparum malaria and involve central nervous system 
(cerebral  malaria),  pulmonary  system  (respiratory 
failure),  renal  system  (acute  renal  failure)  and/or 
hematopietic  system  (severe  anaemia).  As  the 
progression  to  these  complications  can  be  rapid  and 
severe  malaria  is  a  potentially  fatal  disease,  any 
malaria patient must be assessed and treated rapidly, 
and frequent observations are needed to look for early 
signs of systemic complications.
1
According to the most recent definition by World 
Health  Organization  (WHO),  in  a  patient  with  P. 
falciparum asexual parasitaemia and no other obvious 
cause of symptoms, the presence of one or more of the 
clinical  or  laboratory  features  reported  in  Table  1, 
classifies the patient as suffering from severe malaria.
22
This definition has been proposed to assist clinical and 
epidemiological descriptions. In clinical practice, any 
subject for whom severe malaria is suspected, must be 
treated as having severe malaria, although not clearly 
fulfilling the proposed WHO criteria.
7
Cerebral malaria. In order to allow comparability of 
clinical and therapeutic findings, a strict definition of 
cerebral malaria was recommended.
23 In accordance to 
the most recent WHO definition cerebral malaria is a 
severe  P.  falciparum malaria  with  cerebral 
manifestations, usually including coma (Glasgow coma 
scale  <  11,  Blantyre  coma  scale  <  3).  Malaria  with 
coma  persisting  for  >  30  minutes after a  seizure  is 
considered to be cerebral malaria.
22
However,  in  clinical  practice,  subjects  with  any 
degree of altered consciousness and any other sign of 
cerebral  dysfunction  should  be  treated  for  severe 
malaria. Clinical evolution and neurologic findings are 
highly  variable.  Coma  may  onset  suddenly  or 
gradually,  with  initial  drowsiness  (always  worrying 
symptom),  confusion,  disorientation,  delirium  or
agitation.
1,7,8,23 Subjects with cerebral malaria may beMediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 1: Clinical and laboratory features of severe malaria
22
Clinical features:
- impaired consciousness or unrousable coma
- prostration, i.e. generalized weakness so that the patient is unable walk or sit up without assistance
- failure to feed
- multiple convulsions  (more than two episodes in 24 h)
- deep breathing, respiratory distress (acidotic breathing)
- circulatory collapse or shock, systolic blood pressure < 70 mmHg in adults and < 50 mmHg in children
- clinical jaundice plus evidence of other vital organ dysfunction
- haemoglobinuria
- abnormal spontaneous bleeding
- pulmonary oedema (radiological)
Laboratory findings:
- hypoglycaemia (blood glucose < 2.2 mmol/l or < 40 mg/dl)
- metabolic acidosis (plasma bicarbonate < 15 mmol/l)
- severe normocytic anaemia (Hb < 5 g/dl, packed cell volume < 15%)
- haemoglobinuria
-  hyperparasitaemia (> 2% or 100,000/μl in low intensity transmission areas or > 5% or 250,000/μl in areas of high stable malaria   
transmission intensity)
-  hyperlactataemia (lactate > 5 mmol/l)
-  renal impairment (serum creatinine > 265 μmol/l)
open-eyed  but  non-seeing,  and  present  disconjugate 
gaze  and  nistagmus.  Sustained  ocular  deviation, 
generally  upward  or  lateral,  may  be  observed.  They 
may  exhibit  various  forms  of  abnormal  posturing, 
including decerebrate rigidity (extensor posturing, with 
arms and legs extended), decorticate rigidity (extensor 
posturing,  with  arm  flexed  and  legs  extended),  and 
opisthotonus. Neck rigidity and photophobia are rare 
symptoms, but some resistance to passive neck flexion, 
in absence of other signs of meningeal irritation, is not 
uncommon. Seizures, generalized or sometimes focal, 
are  common,  particularly  in  children. 
Electroencephalographic  abnormalities  are  non-
specific. When lumbar puncture is performed in order 
to differentiate cerebral malaria from other causes of 
encephalopathy, the cerebral spinal fluid (CSF) is clear 
and shows a mild lymphocyte pleocytosis  (rarely more 
than 10 cells/μl), and increased protein concentrations 
(rarely exceeding 150 mg/dL). The blood/CSF glucose 
ratio  is  normal,  while  the  lactate  concentration  of 
lactate is raised. Examination of fundus may evidence 
retinal  haemorrhages  (6-37%  of  cases),  while 
papilloedema is rarely seen in cerebral malaria.
24-27
If left untreated, cerebral malaria is probably nearly 
always fatal.
7 Even when treated, cerebral malaria has 
an  approximate  20%  of  mortality  rate  in  adults  and 
15%  in  children.
7 Among  subjects  who  survive,  the 
recovery is relatively rapid with complete reversibility 
of  neurological  signs  and  symptoms.  However, 
neurological sequelae may occur. The most common 
manifestations  are  psychosis,  cranial  nerve  lesions, 
extrapyramidal  tremor,  ataxia,  polyneuropathy  and 
seizures.  Most  of  these  neurologic  disturbances  are 
transient,  resolving  few  days  to  several  weeks  after 
their  onset.  In  some  cases,  particularly  in  children, 
residual  neurological  deficit  may  occur  after  severe 
malaria. Language disorder, motor deficits, cognitive 
impairments  and  epilepsy  have  been  reported  in 
childhood  following  recovery  from  cerebral 
malaria.
28-36
Respiratory  failure.  Respiratory  failure  may  rapidly 
develop at any stage of an acute malaria but, in many 
cases,  occurs  when  subjects  are  already  recovering, 
parasitemia  is  cleared,  and  in  comatose  subjects, 
consciousness has been regained.
1 Pregnant women are 
particularly prone to develop acute respiratory failure. 
The clinical picture is indistinguishable from the adult 
respiratory distress syndrome that develops as a result 
of a systemic or pulmonary infection, severe trauma or 
other  systemic  or  pulmonary  insults.  Tachypnea, 
dispnea, and scattered rales and ronchi on auscultation 
are  the  earliest  warnings.  Patients  with  severe 
hypoxemia may require mechanical ventilation.
Acute  renal  failure.  While  biochemical  evidence  of 
renal dysfunction is frequently observed in otherwise 
uncomplicated malaria, acute  renal failure  is  another 
complication  of  falciparum  malaria,  much  more 
common in adults than among children. Malaria acute 
renal failure may be defined as a urine output of  <400 
mL in 24 h in adults, or 12 mL/kg in 24 h in children, Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
in spite of rehydration, and a serum creatinine of more 
than 265 μmol/l (>3.0 mg/dL).  In practice for initial 
assessment, the serum creatinine alone is used.
22 Acute
renal failure may be present at the subject admission in 
a context of a multiple organ involvement, or occurring 
in the recovery phase of severe malaria.  In the former 
case prognosis is worse. Oliguria is the main feature of 
acute renal failure, although urine output may also be 
normal  or  increased.  In  oliguric  patients,  levels  of 
blood urea nitrogen and serum creatinine are elevated 
and  hyperkalaemia,  hyperphosphatemia, 
hypocaelcemia,  and  metabolic  acidosis  usually 
develop. Dialysis may be necessary in some cases. 
Jaundice and hepatic dysfunction. Jaundice is common 
in adult subjects with severe malaria, while relatively 
rare in children. It is generally mild or moderate, but in 
some  cases  may  be  marked.  Among  the  jaundiced 
subjects,  hyperbilirubinemia  may  be  predominantly 
unconjugated, in case of extensive haemolysis of both 
parasitized  and  unparasitized  erythrocytes,  or 
conjugated,  indicating  hepatocytic  disfunction.  Apart 
from jaundice, signs  of severe liver cell  damage are 
uncommon.  Concentrations  of  transaminases  may  be 
increased up to ten fold, but never to the level observed 
in viral hepatitis. The liver, as well as the spleen, is 
enlarged and tender, especially in young children and 
non immune adults. 
Severe  anaemia.  Severe  malaria  is  associated  with 
development  of  anaemia,  usually  normochromic  and 
normocytic.  However,  in  endemic  areas  the 
morphology may be influenced by the nutritional status 
of the subject and some helminthiasis, resulting in an 
associated microcytic (iron deficiency) and macrocytic 
(folic  acid  deficiency)  component.  The  causative 
mechanisms are multifactorial, including haemolysis of 
infected and uninfected red blood cells, inappropriate 
bone marrow response, and numerous other individual 
factors  (e.g.  bacteraemia,  HIV,  hookworm,  G6PD 
deficiency, vitamin A and vitamin B12 deficiency).
37
In  areas  of  high  endemicity,  severe  anaemia is  a 
particular problem in children, where it can be fatal.
38
In epidemic rather than endemic areas, severe anaemia
may  also  develop  in  adult  population  and  pregnant 
women, especially primiparae, are those at major risk. 
In  accordance  with  the  WHO  definition,  severe 
malarial  anaemia is  defined  in  the  presence  of  a 
haemoglobin level of  5 g/dL, or haematocrit  15%.
22
The  UK  malaria  treatment  guidelines  define  severe 
anaemia when  haemoglobin  level  is  <8  g/dL.
39
Pathological consequences of anaemia are particularly 
likely with such degree of anaemia, however they are 
also  importantly  related  to  the  rapidity  at  which  it 
develops. In this perspective, decisions regarding blood 
transfusion  should  be  taken  at  individual  level. 
Children with severe anaemia and respiratory distress 
will benefit from transfusions that may be lifesaving.
13
Hypoglicemia.  Hypoglicemia  has  been  detected  in 
approximately 8% of adults and up to 30% of children 
with  cerebral malaria.
7 Hypoglicemia  is  a  particular 
complication in  pregnancy.  It may be present  before 
starting antimalarial treatment, representing a sign of 
poor  prognosis.  Hypoglicemia  can  also  result  from 
rapid  infusions  or  prolonged  treatment  with  quinine, 
due  to  its  capability  to  stimulate  insulin  secretion. 
Early diagnosis is essential in order to assure a prompt 
treatment that may be lifesaving, but symptoms may be 
easily  overlooked.  In  fact,  classical  symptoms  of 
hypoglicemia,  such  as  those  induced  by  adrenaline 
secretion  (sweating,  tachycardia,  breathlessness, 
tremor,  anxiety  and  hunger)  or  those  due  to 
dysfunction of central nervous system (impairment of 
consciousness,  seizures,  extensor  posturing),  are 
difficult to distinguish from those caused by malaria. 
Any  subject  with  malaria  and  altered  behaviour  or 
consciousness,  or  seizure,  should  be  evaluated 
immediately for blood glucose level and, if this cannot 
be  possible,  assumed  as  hypoglicemic  and  given 
glucose.
Blackwater  fever.  Blackwater  fever  is  a  syndrome 
presenting  with  passage  of  mahogany-coloured  (or 
‘Coca-Cola’-coloured) urine in association with severe 
intravascular  haemolysis.  The  dark  urine  is  due  to 
haemoglobinuria.
40 Blackwater fever occurs in subjects 
with G-6PD deficiency who take antioxidant drugs or 
foodstuffs,  in  subjects  with  G-6PD  deficiency  who 
have acute malaria after the administration of quinine 
or artemisinin derivative, but also in subject with acute, 
often severe malaria, who have normal red cell G-6PD 
concentrations.
41 Blackwater fever has usually a good 
prognosis  resolving  without  complications.  Only  a 
minority of subjects may develop acute renal failure  as 
a consequence of acute tubular necrosis.
42,43
Complicating  and  associated  infections.  Bacterial 
infection  may  arise  in  subjects  with  severe  and
uncomplicated malaria. Health care acquired infections 
such  those  associated  with  use  of  device  (i.e. 
indwelling catheter or vascular line) or with the poor 
general  condition  of  the  patient  (i.e.  aspiration 
pneumonia or infected decubitus ulcer in patients with 
cerebral malaria and prolonged coma) are  possible.
41
Associated  bacteraemia,  mainly  caused  by  gram 
negative  bacteria,  may  coexist  in  severe  and 
uncomplicated  malaria  and  should  be  suspected, 
especially  in  subjects  with  hypotension  and 
unexplained  deterioration  despite  parasitemia Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
clearance.
22,41 The  threshold  for  administering 
antibiotic treatment should be low in severe malaria.
22
A recent study carried out in a cohort of 506 Kenyan 
children  with  malaria  found  11,7%  prevalence  of 
bacteraemia, with non typhoidal Salmonella spp being 
the  most  common  isolates  (42,4%).
44 Several 
mechanisms are invoked to explain the susceptibility to 
bacteraemia during malaria. Haemolysis can increase 
the  susceptibility  to  invasive  salmonellosis,
45
accumulation  of  haemozoin  pigment  in  monocytes 
impairs  diverse  macrophage  functions,
46 and  severe 
malaria leads to bacterial seeding of the bloodstream 
because of microvascular parasite sequestration in gut 
mucosa.
47
Non-falciparum  severe  malaria.  Although  P. 
falciparum malaria is the major cause of severe malaria 
and  death,  increasing  evidence  has recently emerged 
that  P.  vivax can  also  be  severe  and  even  fatal.
48-51
Besides the rare fatal haemorrhage due to the traumatic 
or  spontaneous  rupture  of  an  enlarged  spleen,  other 
complications of P. vivax infection have been reported, 
including  complications  of  seizure,  shock,  jaundice, 
renal failure, severe anaemia,
51-54 coma
48,49 and acute 
respiratory  distress  syndrome.
55 Recent  studies 
conducted in Indonesia and Papua New Guinea showed 
rates of severe malaria in P. vivax infections as high or 
higher  than  those  observed  in  P.  falciparum
malaria.
48,49 P.  ovale malaria  is    rarely  severe. 
However, respiratory distress has also been reported as 
a rare complication of ovale malaria.
56,57  As far as P. 
knowlesi  malaria  is  concerned,  most  cases  are 
uncomplicated but complications are possible, and in a 
study  conducted in  Malaysia,  approximately  1  in  10 
patients developed potentially fatal complications, with 
a  case  fatality  rate  of  1.8%.
19 The  most  frequent 
complication  was  respiratory  distress,  but  also 
multiorgan  failure,  hypoglicemia,  and  lactic  acidosis 
were observed.
Returning  Travelers.  Imported  malaria  is  an 
increasing public health problem in many non endemic 
countries. Although some cases occur in migrants and 
refugees,  returning  travelers  from  tropical  and 
subtropical areas represent the largest group of persons 
given a diagnosis of malaria. 
The  high  fatality  rate  is  disturbing,  ranging  from 
0.4% to 3% in Europe.
58,59 P. falciparum is responsible 
for  nearly  all  of  these  deaths.  The  fatal  outcome  in 
malaria  cases  is  attributable  to  different  contributing 
factors,  including failure  to  take  or  adhere  to 
recommended  prophylaxis, to  promptly seek medical 
care in  presence of symptoms, to  promptly diagnose 
and  initiate  appropriate  antimalarial  treatment.  The 
protean and nonspecific clinical findings occurring in 
malaria (fever, malaise, headache, myalgias, jaundice 
and  sometimes  gastrointestinal  symptoms  of  nausea, 
vomiting and diarrhoea) may lead physicians who see 
malaria  infrequently  to  a  wrong  diagnosis,  such  as 
influenza  (particularly  during  the  seasonal  epidemic 
flu),  dengue,  gastroenteritis,  typhoid  fever,  viral 
hepatitis,  encephalitis.  It  is  not  uncommon  that  the 
correct  diagnosis  is  performed  at  the  emergency 
admission of a subject with fever and signs of cerebral 
involvement  or  other  complications,  having  being 
visited  a  few  days  before  by  a  physician  who  had 
prescribed antipyretic and antibiotic treatment. 
Specific Population at Increased Risk of Developing 
Severe Malaria. Non immune pregnants in second and 
third trimester are at increased risk of developing life 
threatening malaria and are particularly susceptible to 
develop pulmonary oedema and hypoglycemia. Foetal 
death  and  premature  labour  are  common.
60-63 People 
with  immunosuppression  related  to  HIV  show  an 
impaired  immune  control  of  malaria.  There  is  an 
increasing  risk  of  illness,  increased  parasitemia  and 
severe  malaria. Therapeutic responses to  antimalarial 
treatment  are  impaired  so  treatment  failure  rates  are 
increased.  Drug  interactions  between  antiretrovirals 
and antimalarials have not yet been studied adequately. 
Trimethoprim-sulphamethoxazole  prescribed  as 
prophylaxis  for  opportunistic  infection  gives    some 
protection  also  for  malaria.  Co-infected  pregnant 
women are at risk for higher parasite density, anaemia
and malarial infection of the placenta. Children born to 
women with HIV and malaria infection have low birth 
weight and are more likely to die during infancy.
64-69
Malaria in non-HIV immunocompromised subjects is 
less  studied.  Malaria  in  transplant  recipients  can  be 
caused  by  graft-born  or  blood  born  infection
70,71 or 
reactivation  of  previous  infection  due  to 
immunosuppression.
72 The clinical picture of malaria 
in transplant recipients is usually severe, owing to the 
impaired  immune  response.
73 It  is  characterized  by 
pyrexia,  which  may  lack  the  typical  periodicity  or 
rigors. Anaemia is severe, being typically haemolytic 
and  occasionally  haemophagocytic.
74 Acute  graft 
dysfunction  may  occur  as  a  consequence  of  the 
haemodynamic consequences of falciparum infection.
75
Presence of the sickle cell trait confers some protection 
against malaria, however, for  those with homozygous 
sickle-cell disease, malaria is regarded as a significant 
cause  of  morbidity  and  mortality,  producing  further 
haemolysis  against  the  background  of  that  due  to 
sickle-cell  disease  itself.
76 Subjects    who  have  no 
spleen or whose splenic function is severely impaired 
are  at  particular risk of  severe malaria, and malarial 
parasitaemia in asplenic individuals may rise rapidly to 
very  high  levels.
77 Post-splenectomy  episode  of  P. Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
falciparum malaria has been reported in immigrants.
78
Other  groups  at  increased  risk  for  developping 
severe malaria are malnourished children, elderly and 
those with comorbidities.
79-81
Hyper-Reactive Malaria Splenomegaly. In areas with 
intense  transmission,  repeated  plasmodial  infections 
may generate a long-term stimulation of the immune 
system and determine a syndrome named hyperreactive 
malaria splenomegaly (HMS). From the clinical point 
of view, most subjects present with a huge spleen (to 
the level of umbilicus or below), abdominal distension, 
and a dragging left-sided abdominal pain, sometimes 
so sharp to suggest perisplenitis or splenic infarction.
8
Most  of  HMS  subjects  have  also  non-tender 
hepatomegaly.  Secondary  hypersplenism  may  be 
associated to HMS, showing its typical blood picture 
with  normochromic,  normocytic  anaemia, 
reticulocytosis,  leucopenia  and  thrombocytopenia.  
Polyclonal hypergammaglobulinemia with high serum 
concentrations  of  IgM,  high  titers  of  antimalarial 
antibodies  and  autoantibodies  (antinuclear  factor, 
rheumatoid  factors  etc)  are  usually  present. 
Microscopic  examination  of  blood  films  is  usually 
negative. In industrialized countries, PCR analysis for 
malarial  DNA  can  provide  further  evidence  for 
diagnosis of HMS.
82 Diagnostic criteria include: long-
term  stay  in  endemic  areas,  massive  and  persistent 
splenomegaly,  anaemia,  high  levels  of  serum  IgM, 
increased levels of malarial antibodies and clinical and 
immunological  response  to  antimalarial  treatment.
83
Left untreated, HMS may lead to a cachectic condition 
with  increased  susceptibility  to  potentially  fatal 
infections.  In endemic areas, HMS can be successfully 
treated with antimalarial required for the  duration of 
malaria  exposure.
7 HMS  has  been  described  in 
immigrants  from  Africa  and  in  some  European 
expatriates living in endemic countries.
82,84-87 In these 
studies, subjects with HMS were successfully treated 
by a short-term antimalarial therapy.
Conclusions. In conclusion, although fever represents 
the  cardinal  feature,  clinical  findings  in  malaria  are 
extremely diverse and may range in severity from mild 
headache  to  serious  complications  leading  to  death, 
particularly in falciparum malaria.  Prompt diagnosis 
and appropriate treatment are then crucial to prevent 
morbidity and fatal outcomes. In fact, severe malaria is 
a  life  threatening  but  treatable  disease.    Physicians 
should be aware that malaria is not a clinical diagnosis 
but  must  be  diagnosed,  or  excluded,  by  performing 
microscopic  examination of  blood  films.
7 A  positive 
blood test can quickly confirm the clinical suspicion of 
malaria. However, subjects with symptoms compatible 
with  severe disease, should be  treated  presumptively 
for  P.  falciparum,  even  if  the  initial  blood  film  is 
negative or microscopy, or rapid diagnostic tests, are 
not available.
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